Clinical Trial Update: Bioequivalence Study of Dutasteride Five 0.1 mg and One 0.5 mg Soft Gelatin Capsules in Healthy Male Volunteers [Phase 1]

View source ↗

Summary

Phase 1 bioequivalence study comparing five 0.1 mg dutasteride capsules to one 0.5 mg capsule in healthy male volunteers, conducted for alopecia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alopecia

Drugs mentioned

• DUTASTERIDE (Dutasteride)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Alopecia | Phase 1 | Status: COMPLETED